Neurophysiological and Behavioral Study of the Cognitive Deficits Associated With Cerebral Small Vessel Disease in the SHIVA Cohort. SHIVA-CogNeurophys
SHIVA-CogNeuro
1 other identifier
interventional
80
1 country
1
Brief Summary
Cerebral small vessel disease (cSVD) is characterized by an alteration of the structure and function of small penetrating brain arteries. Highly prevalent in older individuals from the general population, it represents a leading cause of stroke and a major contributor to cognitive decline and risk of dementia. Better detection and management of covert cSVD would have a major impact on preventing disability and costs related to stroke, cognitive impairment and dementia. The aim of the present study is to identify novel electroencephalographic (EEG) biomarkers of the cognitive deficits associated with cSVD, and how these biomarkers and cognitive performance are affected by personalized cognitive training or transcranial alternating current stimulation (tACS), a non-invasvie brain stimulation technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2025
CompletedFirst Posted
Study publicly available on registry
July 16, 2025
CompletedStudy Start
First participant enrolled
August 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 7, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 7, 2028
February 2, 2026
July 1, 2025
2.6 years
July 4, 2025
January 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
EEG signal power
The primary outcome measure is the average EEG signal power (across different frequency bands and for various electrodes) between the two participant groups with either minor or extensive cSVD
Day 0, Day 26, Day 33
Study Arms (2)
Personalized cognitive training using an AI algorithmwith a non-linear learning path adapted to each
EXPERIMENTALPersonalized cognitive training using an AI algorithm (zone of proximal development and empirical success - ZPDES - multi-arm algorithm), with a non-linear learning path adapted to each participant.
Traditional cognitive training
ACTIVE COMPARATORTraditional cognitive training using a "staircase" method, featuring a linear progression.
Interventions
All interventions will be carried out for both groups of participants, with either minimal or extensive cSVD. Upon enrollment, each participant will undergo two hospital visits (visit 1 at day 0, visit 2 at day 7), followed by a home-based cognitive training across 10 days (days 15-24), two more hospital visits (visit 3 at day 26, visit 4 at day 33), and finally a follow-up cognitive testing at home after 6 months.
Eligibility Criteria
You may qualify if:
- Patients included or previously included in the SHIVA cohort
- Basic computer skills (ability to open a browser, use a mouse and keyboard)
- Access to a personal computer with an internet connection
- Independent in Activities of Daily Living (ADL) with a score ≥ 5/6, and in Instrumental Activities of Daily Living (IADL) with a score ≥ 4/8
- Informed and written consent signed by the participant and the investigating physician for this study
You may not qualify if:
- Motor impairments preventing the use of a keyboard and mouse (e.g., motor issues related to severe hand osteoarthritis)
- Depressive symptoms indicated by a score of 2 to 4 on the mini Geriatric Depression Scale (mini GDS), which includes 4 items
- Age-related macular degeneration (AMD)
- Untreated glaucoma
- Untreated psychiatric conditions that interfere with cognitive assessments
- Diagnosed attention deficit disorder with or without hyperactivity or patients who could not complete all cognitive tests required in the SHIVA cohort
- Systemic diseases that cause cognitive changes, such as obesity and metabolic disorders
- History of epilepsy or seizures
- Scalp sensitivity or skin lesions (dermatitis, wounds, etc.)
- Contraindications for the use of electrical stimulation:
- Surgical clips, metal sutures, staples, stents
- Osteosynthesis material in the head or neck
- Pacemaker
- Implanted hearing aid
- Ocular foreign bodies, shrapnel, bullets
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Bordeaux, Hôpital Pellegrin, Unité Neurovasculaire
Bordeaux, 33000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2025
First Posted
July 16, 2025
Study Start
August 7, 2025
Primary Completion (Estimated)
March 7, 2028
Study Completion (Estimated)
March 7, 2028
Last Updated
February 2, 2026
Record last verified: 2025-07